发明名称 |
Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments |
摘要 |
The invention relates to the use of anti-IL-6 antibodies or antibody fragments containing a specific epitopic specificity to treat conditions involving elevated Il-6. In some embodiments the anti-IL-6 antibodies contain specific CDRs. |
申请公布号 |
US8900580(B2) |
申请公布日期 |
2014.12.02 |
申请号 |
US200912624778 |
申请日期 |
2009.11.24 |
申请人 |
AlderBio Holdings LLC |
发明人 |
Garcia-Martinez Leon;Jensen Anne Elisabeth Carvalho;Olson Katie;Dutzar Ben;Latham John;Kovacevich Brian;Smith Jeffrey T. L.;Litton Mark;Schatzman Randall |
分类号 |
A61K39/395;A61K51/10;A61K49/00;A61K39/00;C07K16/24;C12P21/08;C12N15/63 |
主分类号 |
A61K39/395 |
代理机构 |
LeClairRyan, a professional corporation |
代理人 |
LeClairRyan, a professional corporation ;Teskin Robin L. |
主权项 |
1. A method of treating a disease or condition associated with elevated human interleukin-6 (IL-6), comprising administering a therapeutically effective amount of an anti-IL-6 antibody or antibody fragment to a subject in need thereof, wherein the antibody or antibody fragment comprises:
a variable light chain polypeptide comprising the CDRs of SEQ ID NOs:4, 5 and 6 and possessing at least 90% identity to the variable light chain polypeptide of SEQ ID NO:709, and a variable heavy chain polypeptide comprising the CDRs of SEQ ID NOs:7, 8 or 120, and 9 and possessing at least 90% identity to the variable heavy chain polypeptide of SEQ ID NO:657, and; wherein the antibody or antibody fragment specifically binds to IL-6 and antagonizes one or more activities associated with IL-6 and specifically binds to the same epitope(s) on IL-6 as an anti-IL-6 antibody comprising the variable light chain polypeptide of SEQ ID NO:709 and the variable heavy chain polypeptide of SEQ ID NO:657. |
地址 |
Las Vegas NV US |